Citation Impact
Citing Papers
Opioid analgesia: perspectives on right use and utility.
2007
The efficacy and value of emergency medicine: a supportive literature review
2011 Standout
Effects of oral THC maintenance on smoked marijuana self-administration
2002
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
2008 Standout
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome
2004
Enhancement of transdermal delivery of 6-β-naltrexol via a codrug linked to hydroxybupropion
2006
Critical assessment of how to study addiction and its treatment: Human and non-human animal models
2005
Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice
2004
The psychology and neurobiology of addiction: an incentive–sensitization view
2000
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system
2004
Schizophrenia
2009 Standout
Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose–response analysis
2003
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Vaccines Against Drug Abuse
2011
Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior
2004
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
2011
Smoking in parents of children with asthma and bronchiolitis in a pediatric emergency department
2002
Surgical and pharmacological suppression of glucocorticoids prevents the enhancement of morphine conditioned place preference by uncontrollable stress in rats
2004
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Mechanisms of neurotransmitter release by amphetamines: A review
2005 Standout
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
2007
Endogenous opiates: 1999
2000
Opioid dependence and addiction during opioid treatment of chronic pain
2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Validity of four pain intensity rating scales
2011 Standout
Interaction between glucocorticoid hormones, stress and psychostimulant drugs*
2002
Oral naltrexone maintenance treatment for opioid dependence
2011
Sex Differences and Hormonal Influences on Response to Cold Pressor Pain in Humans
2006
Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers
2007
Incentive‐sensitization and addiction
2001 Standout
Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery
2010
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Transdermal drug delivery
2008 Standout
Tapering Long-term Opioid Therapy in Chronic Noncancer Pain
2015
Buprenorphine Antinociception is Abolished, but Naloxone-Sensitive Reward is Retained, in μ-Opioid Receptor Knockout Mice
2004
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
Stress and Cocaine Addiction
2002
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Lack of Self-Administration of Cocaine in Dopamine D1Receptor Knock-Out Mice
2007 Nobel
Self-administration of cannabinoids by experimental animals and human marijuana smokers
2005
Pharmacotherapy of schizophrenia with comorbid substance use disorder — Reviewing the evidence and clinical recommendations
2008
A Public Health Approach to Emergency Medicine: Preparing for the Twenty‐first Century
1994
Favorable Mortality Profile of Naltrexone Implants for Opiate Addiction
2010
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Are Opioid-Dependent/Tolerant Patients Impaired in Driving-Related Skills? A Structured Evidence-Based Review
2003
Microneedles for drug and vaccine delivery
2012 Standout
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats
2003
Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
2009
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22Some of this material was published previously in: Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev 1999;20:96–142.
2000
Unlimited Access to Heroin Self-Administration: Independent Motivational Markers of Opiate Dependence
2006
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Neurocircuitry of Addiction
2009 Standout
Amphetamine-Induced Dopamine Release: Markedly Blunted in Cocaine Dependence and Predictive of the Choice to Self-Administer Cocaine
2007
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
2005
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior
2003
Dopamine, learning and motivation
2004 Standout
Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats
2007
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
Opioid Analgesia: Perspectives onRight Use and Utility
2007
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
β-Phenylethylamines and the isoquinoline alkaloids
2004
Opioid maintenance: a comparative review of pharmacological strategies
2006
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
2003
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Existing and Future Drugs for the Treatment of the Dark Side of Addiction
2015
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Opioid Complications and Side Effects
2008 Standout
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
2007
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
2007
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
The psychology and neurobiology of addiction: an incentive–sensitization view
2000
Works of Eric D. Collins being referenced
The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans
1998
The emergency department as part of a successful strategy for increasing adult immunization
1988
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
2002
Effect of a selective dopamine D 1 agonist (ABT-431) on smoked cocaine self-administration in humans
1999
Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in Humans
2009
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans
2001
Intravenous Buprenorphine Self-Administration by Detoxified Heroin Abusers
2002
Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans
1998
Effects of an alternative reinforcer on intravenous heroin self-administration by humans
1998
The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.
2003
Self-Administration of Intravenous Buprenorphine and the Buprenorphine/Naloxone Combination by Recently Detoxified Heroin Abusers
2002
Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans
1999
Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
2005
Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans
1999
Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction
2005
Behavioral naltrexone therapy
2002
Choice between money and intranasal heroin in morphine-maintained humans
1997
Flupenthixol Treatment for Cocaine Abusers with Schizophrenia: A Pilot Study
1998
Should opioid Analgesics Be Used in the Management of Chronic Pain in Opiate Addicts?
2003
Should Opioid Analgesics Be Used in the Management of Chronic Pain in Opiate Addicts?
2003